Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | RNF26 | Human | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RNF26 mRNA | CTD | PMID:22079256 | RNF26 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Rnf26 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of RNF26 mRNA | CTD | PMID:21570461 | RNF26 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Rnf26 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RNF26 mRNA | CTD | PMID:33387578 | RNF26 | Human | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Rnf26 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of RNF26 mRNA | CTD | PMID:26251327 | RNF26 | Human | 3,4-methylenedioxymethamphetamine | increases methylation | ISO | Rnf26 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased methylation of RNF26 promoter | CTD | PMID:26251327 | RNF26 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RNF26 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RNF26 mRNA | CTD | PMID:28628672 | RNF26 | Human | 4,4'-diaminodiphenylmethane | increases expression | ISO | Rnf26 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of RNF26 mRNA | CTD | PMID:18648102 | RNF26 | Human | acetylsalicylic acid | increases expression | EXP | | 6480464 | Aspirin results in increased expression of RNF26 mRNA | CTD | PMID:11906190 | RNF26 | Human | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of RNF26 mRNA | CTD | PMID:32763439 | RNF26 | Human | aflatoxin B1 | decreases expression | ISO | Rnf26 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of RNF26 mRNA | CTD | PMID:19770486 | RNF26 | Human | amphetamine | decreases expression | ISO | Rnf26 (Rattus norvegicus) | 6480464 | Amphetamine results in decreased expression of RNF26 mRNA | CTD | PMID:30779732 | RNF26 | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of RNF26 mRNA | CTD | PMID:33212167 | RNF26 | Human | atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of RNF26 mRNA | CTD | PMID:22378314 | RNF26 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of RNF26 promoter | CTD | PMID:27901495 | RNF26 | Human | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:20382639 | RNF26 | Human | bisphenol A | increases expression | ISO | Rnf26 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of RNF26 mRNA | CTD | PMID:25181051 and PMID:34947998 | RNF26 | Human | bisphenol A | decreases expression | ISO | Rnf26 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of RNF26 mRNA | CTD | PMID:35598803 | RNF26 | Human | bisphenol A | increases methylation | ISO | Rnf26 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of RNF26 gene | CTD | PMID:28505145 | RNF26 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RNF26 mRNA | CTD | PMID:28628672 | RNF26 | Human | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RNF26 mRNA | CTD | PMID:28628672 | RNF26 | Human | bisphenol F | increases expression | ISO | Rnf26 (Mus musculus) | 6480464 | bisphenol F results in increased expression of RNF26 mRNA | CTD | PMID:38685157 | RNF26 | Human | buspirone | decreases expression | ISO | Rnf26 (Rattus norvegicus) | 6480464 | Buspirone results in decreased expression of RNF26 mRNA | CTD | PMID:24136188 | RNF26 | Human | cadmium dichloride | increases expression | ISO | Rnf26 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased expression of RNF26 mRNA | CTD | PMID:33453195 | RNF26 | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of RNF26 mRNA | CTD | PMID:38568856 | RNF26 | Human | carbon nanotube | increases expression | ISO | Rnf26 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | RNF26 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to RNF26 gene] | CTD | PMID:28238834 | RNF26 | Human | chromium(6+) | multiple interactions | EXP | | 6480464 | [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of RNF26 mRNA | CTD | PMID:38479592 | RNF26 | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of RNF26 mRNA | CTD | PMID:27594783 | RNF26 | Human | cobalt dichloride | decreases expression | ISO | Rnf26 (Rattus norvegicus) | 6480464 | cobaltous chloride results in decreased expression of RNF26 mRNA | CTD | PMID:24386269 | RNF26 | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of RNF26 mRNA | CTD | PMID:19549813 | RNF26 | Human | coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of RNF26 mRNA | CTD | PMID:19167446 | RNF26 | Human | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | RNF26 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of RNF26 mRNA | CTD | PMID:25562108 | RNF26 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RNF26 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RNF26 mRNA | CTD | PMID:28628672 | RNF26 | Human | dicrotophos | increases expression | EXP | | 6480464 | dicrotophos results in increased expression of RNF26 mRNA | CTD | PMID:28302478 | RNF26 | Human | Enterolactone | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RNF26 mRNA | CTD | PMID:19167446 | RNF26 | Human | epoxiconazole | decreases expression | ISO | Rnf26 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of RNF26 mRNA | CTD | PMID:35436446 | RNF26 | Human | ethanol | affects expression | ISO | Rnf26 (Mus musculus) | 6480464 | Ethanol affects the expression of RNF26 mRNA | CTD | PMID:30319688 | RNF26 | Human | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of RNF26 mRNA | CTD | PMID:20044591 | RNF26 | Human | hypochlorous acid | decreases expression | ISO | Rnf26 (Mus musculus) | 6480464 | Hypochlorous Acid results in decreased expression of RNF26 mRNA | CTD | PMID:19376150 | RNF26 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RNF26 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RNF26 mRNA | CTD | PMID:28628672 | RNF26 | Human | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of RNF26 mRNA | CTD | PMID:28988120 | RNF26 | Human | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of RNF26 mRNA | CTD | PMID:23649840 | RNF26 | Human | nimesulide | decreases expression | ISO | Rnf26 (Rattus norvegicus) | 6480464 | nimesulide results in decreased expression of RNF26 mRNA | CTD | PMID:24136188 | RNF26 | Human | nitrofen | decreases expression | ISO | Rnf26 (Rattus norvegicus) | 6480464 | nitrofen results in decreased expression of RNF26 mRNA | CTD | PMID:26720608 | RNF26 | Human | ozone | multiple interactions | ISO | Rnf26 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of RNF26 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of RNF26 mRNA | CTD | PMID:34911549 | RNF26 | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of RNF26 mRNA | CTD | PMID:22230336 | RNF26 | Human | paracetamol | decreases expression | ISO | Rnf26 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of RNF26 mRNA | CTD | PMID:33387578 | RNF26 | Human | pirinixic acid | increases expression | ISO | Rnf26 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of RNF26 mRNA | CTD | PMID:17426115 | RNF26 | Human | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RNF26 mRNA | CTD | PMID:22079256 | RNF26 | Human | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of RNF26 mRNA | CTD | PMID:22079256 | RNF26 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with Resveratrol] results in increased expression of RNF26 mRNA and [Plant Extracts co-treated with Resveratrol] results in decreased expression of RNF26 mRNA | CTD | PMID:19167446 and PMID:23557933 | RNF26 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of RNF26 mRNA | CTD | PMID:38568856 | RNF26 | Human | sulindac | decreases expression | EXP | | 6480464 | Sulindac results in decreased expression of RNF26 mRNA | CTD | PMID:11906190 | RNF26 | Human | thioacetamide | decreases expression | ISO | Rnf26 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of RNF26 mRNA | CTD | PMID:34492290 | RNF26 | Human | thiram | decreases expression | EXP | | 6480464 | Thiram results in decreased expression of RNF26 mRNA | CTD | PMID:38568856 | RNF26 | Human | trichloroethene | decreases expression | ISO | Rnf26 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of RNF26 mRNA | CTD | PMID:33387578 | RNF26 | Human | trimellitic anhydride | increases expression | ISO | Rnf26 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of RNF26 mRNA | CTD | PMID:19042947 | RNF26 | Human | troglitazone | decreases expression | ISO | Rnf26 (Mus musculus) | 6480464 | troglitazone results in decreased expression of RNF26 mRNA | CTD | PMID:28973697 | RNF26 | Human | trovafloxacin | decreases expression | ISO | Rnf26 (Rattus norvegicus) | 6480464 | trovafloxacin results in decreased expression of RNF26 mRNA | CTD | PMID:24136188 | RNF26 | Human | vinclozolin | decreases expression | ISO | Rnf26 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of RNF26 mRNA | CTD | PMID:23034163 | |